NPPB and ocular melanoma: Furthermore, considering the results of the subgroup analysis, which showed that the effect of OM was particularly large in the group with a LVEF less than 28% and high NT-proBNP, OM can be positioned as a drug that can be effective in patients with severe cardiomyopathy.